ABAT
4-aminobutyrate aminotransferase, mitochondrial
Also known as: GABA-T, GABAT, GABT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P80404
- Gene
- ABAT
- Ensembl
- ENSG00000183044
- Chromosome
- 16
- Canonical length
- 500 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
4-aminobutyrate aminotransferase (ABAT) is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde. The active enzyme is a homodimer of 50-kD subunits complexed to pyridoxal-5-phosphate. The protein sequence is over 95% similar to the pig protein. GABA is estimated to be present in nearly one-third of human synapses. ABAT in liver and brain is controlled by 2 codominant alleles with a frequency in a Caucasian population of 0.56 and 0.44. The ABAT deficiency phenotype includes psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
500 residues, UniProt reviewed canonical sequence.
>P80404|ABAT
1 MASMLLAQRL ACSFQHSYRL LVPGSRHISQ AAAKVDVEFD YDGPLMKTEV PGPRSQELMK
61 QLNIIQNAEA VHFFCNYEES RGNYLVDVDG NRMLDLYSQI SSVPIGYSHP ALLKLIQQPQ
121 NASMFVNRPA LGILPPENFV EKLRQSLLSV APKGMSQLIT MACGSCSNEN ALKTIFMWYR
181 SKERGQRGFS QEELETCMIN QAPGCPDYSI LSFMGAFHGR TMGCLATTHS KAIHKIDIPS
241 FDWPIAPFPR LKYPLEEFVK ENQQEEARCL EEVEDLIVKY RKKKKTVAGI IVEPIQSEGG
301 DNHASDDFFR KLRDIARKHG CAFLVDEVQT GGGCTGKFWA HEHWGLDDPA DVMTFSKKMM
361 TGGFFHKEEF RPNAPYRIFN TWLGDPSKNL LLAEVINIIK REDLLNNAAH AGKALLTGLL
421 DLQARYPQFI SRVRGRGTFC SFDTPDDSIR NKLILIARNK GVVLGGCGDK SIRFRPTLVF
481 RDHHAHLFLN IFSDILADFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 323 nTPM
Expression across tissuesHPA
Tissue
- liver: 323 nTPM
- pancreas: 130 nTPM
- basal ganglia: 129 nTPM
- cerebral cortex: 125 nTPM
- kidney: 125 nTPM
- hypothalamus: 110 nTPM
Single-cell type
- hepatocytes: 350 nCPM
- somatotrophs: 227 nCPM
- ependymal cells: 173 nCPM
- retinal amacrine cells: 155 nCPM
- corticotrophs: 152 nCPM
- oligodendrocyte progenitor cells: 147 nCPM
Immune cell
- neutrophil: 6.1 nTPM
- non-classical monocyte: 4.2 nTPM
- eosinophil: 2.7 nTPM
- intermediate monocyte: 2.2 nTPM
- classical monocyte: 1.9 nTPM
- gdT-cell: 1.5 nTPM
Brain region
- thalamus: 264 nTPM
- pons: 262 nTPM
- hypothalamus: 254 nTPM
- midbrain: 193 nTPM
- basal ganglia: 188 nTPM
- cerebral cortex: 180 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ABAT.
Disease | AllUniProt
Conditions ABAT is implicated in, by any mechanism.
- GABA-transaminase deficiency (GABATD) MIM:613163
Disease | GeneticClinVar
39 pathogenic / likely-pathogenic of 800 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Gamma-aminobutyric acid transaminase deficiency
- Inborn genetic diseases
- ABAT-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cerebellum development
- copulation
- exploration behavior
- gamma-aminobutyric acid biosynthetic process
- gamma-aminobutyric acid catabolic process
- gamma-aminobutyric acid metabolic process
- locomotory behavior
- negative regulation of blood pressure
- negative regulation of dopamine secretion
- negative regulation of gamma-aminobutyric acid secretion
- nervous system process
- positive regulation of aspartate secretion
- positive regulation of dopamine metabolic process
- positive regulation of heat generation
- positive regulation of inhibitory postsynaptic potential
- positive regulation of insulin secretion
- positive regulation of prolactin secretion
- positive regulation of uterine smooth muscle contraction
- response to cocaine
- response to ethanol
- response to hypoxia
- response to iron ion
- response to nicotine
- response to xenobiotic stimulus
Molecular functions
- identical protein binding
- iron-sulfur cluster binding
- metal ion binding
- pyridoxal phosphate binding
- (S)-3-amino-2-methylpropionate transaminase activity
- 4-aminobutyrate:2-oxoglutarate transaminase activity
- succinate-semialdehyde dehydrogenase binding
Cellular components
- mitochondrial matrix
- mitochondrion
- 4-aminobutyrate transaminase complex
Protein domainsUniProt · Pfam · InterPro
- Aminotransferase class-III
- Pyridoxal phosphate-dependent transferase, major domain
- Pyridoxal phosphate-dependent transferase, small domain
- Pyridoxal phosphate-dependent transferase
- Aminotransferases class-III pyridoxal-phosphate attachment site
- Aminotransferase class-III
- 4-aminobutyrate aminotransferase, eukaryotic
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABAT as an antibody target. Whether an autoantibody or antibody against ABAT could matter depends on whether native ABAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABAT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ABAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...